Current

Request for Proposals - Supply of abiraterone and novel androgen receptor inhibitors (nARIs)

Tender ID: 618678

Tender Details

⁠⁠⁠Pharmac invites proposals for the supply of abiraterone and novel androgen receptor inhibitors in New Zealand.This request for proposals (RFP) letter incorporates the following schedules and documents ...

Pricing Plans

Only pay for what you need - our plans are priced based on the number of users, regions and tender alerts you need. Cancel anytime.

Suppliers

Lite

Suitable for sole traders & small businesses.

$67per month

Pay monthly

Features

  • 1 user
  • 1 region, state or territory
  • 2 tender alert profiles
  • Unlimited alert emails
  • Tender watchlist
  • Future tenders
  • Awarded tenders
  • Dedicated account manager
  • Free resources
  • Phone support
Suppliers Buyers

Core

Suitable for medium-sized businesses.

$99per month

Pay monthly

Features

  • 10 users
  • Australia
  • 20 tender alert profiles
  • Unlimited alert emails
  • Tender watchlist & awarded tenders
  • Future tenders
  • Dedicated account manager
  • Free resources & phone support
  • 2 current tender ads
  • API access
Suppliers Buyers

Premium

Suitable for large enterprise organisations.

$145per month

Pay monthly

Features

  • 20 users
  • Australia & New Zealand
  • Unlimited tender alert profiles
  • Unlimited alert emails
  • Tender watchlist & awarded tenders
  • Future tenders
  • Dedicated account manager
  • Free resources & phone support
  • 5 current tender ads
  • API access
Not sure if Australian Tenders is right for you?

Location

New Zealand   :   Auckland   :   Bay of Plenty   :   Canterbury   :   Chatham Islands   :   Gisborne   :   Hawke's Bay   :   Kermadec   :   Manawatu-Wanganui   :   Marlborough   :   Nelson   :   Northland   :   Otago   :   Southland   :   Subantartic   :   Taranaki   :   Tasman-Nelson   :   Three Kings   :   Waikato   :   Wellington   :   West Coast  

Category

Drugs & Pharmaceutical Products  

Similar Tenders

Active opportunities matching this tender's categories and regions.

Future Procurement Opportunity (FPO) - Supply of infliximab, rituximab, and tocilizumab to Health New Zealand hospitals

⁠⁠⁠Pharmac is planning on issuing a competitive process for the supply of infliximab, rituximab, and tocilizumab to Health New Zealand hospitals. This competitive process may result in the maintenance o...

NZ
30 September 2026
Future